Improving antichagasic drug discovery through stage-specific monitoring of Trypanosoma cruzi

About 6-7 million people are infected with Trypanosoma cruzi, a protozoan parasite causing Chagas’ disease. Most of the symptoms appear in the chronic phase of Chagas’ disease: cardiomyopathies and mega-syndromes of the digestive tract. There is a high need for new drug, as the only two...

Ongoing
01.03.2016 - 28.02.2019
Research project
Fudacao Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro (FAPERJ) , Burckhardt-Bürgin Foundation
Parasite Chemotherapy Group
Marcel Kaiser
Ongoing
01.01.2016 - 31.12.2018
Research project
Wellcome Trust
Parasite Chemotherapy Group
Marcel Kaiser